Patents by Inventor Yonggang Ji

Yonggang Ji has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240002243
    Abstract: The present invention provides a method for separation and recovery of boron trifluoride and complexes thereof in an olefin polymerization reaction.
    Type: Application
    Filed: October 27, 2021
    Publication date: January 4, 2024
    Inventors: Tong LIU, Yuanyuan CAO, Yulong WANG, Libo WANG, Xianming XU, Hongping LI, Enhao SUN, Xiuhui WANG, Wei SUN, Han GAO, Hongling CHU, Yongjun ZHANG, Yonggang JI, Kecun MA, Yan JIANG, Qian CHEN, Hongliang HUO, Qi YU
  • Publication number: 20040137589
    Abstract: Presented are a novel myosin-like protein particularly expressed in human heart and muscle, isolated nucleic acids encoding the myosin-like protein, compounds and compositions derivable directly or indirectly therefrom, and diagnostic and therapeutic methods for using the same.
    Type: Application
    Filed: November 26, 2003
    Publication date: July 15, 2004
    Inventors: Yizhong Gu, Yonggang Ji, Sharron Gaynor Penn, David Kagen Hanzel, David-Russell Rank, Wensheng Chen, Mark E. Shannon
  • Patent number: 6686188
    Abstract: Presented are a novel myosin-like protein particularly expressed in human heart and muscle, isolated nucleic acids encoding the myosin-like protein, compounds and compositions derivable directly or indirectly therefrom, and diagnostic and therapeutic methods for using the same.
    Type: Grant
    Filed: May 25, 2001
    Date of Patent: February 3, 2004
    Assignee: Amersham PLC
    Inventors: Yizhong Gu, Yonggang Ji, Sharron Gaynor Penn, David Kagen Hanzel, David Russell Rank, Wensheng Chen, Mark E. Shannon
  • Publication number: 20020123474
    Abstract: The invention provides isolated nucleic acids that encode human GRBP2, and fragments thereof, vectors for propagating and expressing human GRBP2 nucleic acids, host cells comprising the nucleic acids and vectors of the present invention, proteins, protein fragments, and protein fusions of the human GRBP2, and antibodies thereto. The invention further provides transgenic cells and non-human organisms comprising human GRBP2 nucleic acids, and transgenic cells and non-human organisms with targeted disruption of the endogenous orthologue of the human GRBP2 gene. The invention further provides pharmaceutical formulations of the nucleic acids, proteins, and antibodies of the present invention, and diagnostic, investigational, and therapeutic methods based on the human GRBP2 nucleic acids, proteins, and antibodies of the present invention.
    Type: Application
    Filed: June 29, 2001
    Publication date: September 5, 2002
    Inventors: Mark E. Shannon, Yonggang Ji
  • Publication number: 20020048800
    Abstract: Presented are a novel myosin-like protein particularly expressed in human heart and muscle, isolated nucleic acids encoding the myosin-like protein, compounds and compositions derivable directly or indirectly therefrom, and diagnostic and therapeutic methods for using the same.
    Type: Application
    Filed: May 25, 2001
    Publication date: April 25, 2002
    Inventors: Yizhong Gu, Yonggang Ji, Sharron G. Penn, David K. Hanzel, David R. Rank, Wensheng Chen, Mark E. Shannon